Search

Sun Pharmaceutical Inds.

Sector: Healthcare | Industry: Drugs & Pharma
R 392.55 2.80  | 0.72% -29.81% 35.32 94,137.91
NSE Price: Jun 14, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jun 14, 15:59 392.55 2.80 0.72% 390.00 389.75 9,786,375 376.55 - 394.85
BSE Jun 14, 2019 392.35 2.25 0.58% 390.00 390.10 596,609 376.85 - 394.90
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13
Income StatementR Cr
Operating Revenue29,065.9126,415.5431,308.1428,108.6127,392.01 16,080.3611,299.86
Other Income1,025.49912.081,030.20658.25637.89 592.59422.23
Total Income30,091.4027,327.6232,338.3428,766.8628,029.90 16,672.9511,722.09
Total Expenditure22,758.3220,880.7321,625.9219,950.2919,615.54 9,120.956,437.76
Operating Profit7,333.086,446.8910,712.428,816.578,414.36 7,552.005,284.33
Interest555.25517.57399.80523.24578.99 44.1943.16
PBDT6,777.835,929.3210,312.628,293.337,835.37 7,507.815,241.17
Depreciation1,753.251,499.841,264.751,037.531,194.72 409.23336.17
PBT & Exceptional Items5,024.584,429.489,047.877,255.806,640.65 7,098.584,905.00
Exceptional Items-1,214.38-950.50--685.17-237.75 -2,517.41-583.58
Profit before Tax3,810.203,478.989,047.876,570.636,402.90 4,581.174,321.42
Provision for Tax624.88845.191,211.57913.77914.69 702.17845.55
Profit after Tax3,185.322,633.797,836.305,656.865,488.21 3,879.003,475.87
Minority Interest-542.43-446.80-881.86-1,112.60-936.27 -737.53-486.28
Share of Associate-1.46-25.449.931.45-12.56 --
Consolidated Profit2,641.422,161.556,964.374,545.714,539.38 3,141.472,983.06
 
LiabilitiesR Cr
Share Capital239.93239.93239.93240.66207.12 207.12103.56
Total Reserves41,169.1337,860.6336,397.1032,736.2625,374.38 18,317.8314,886.17
Shareholder's Funds41,409.0638,100.5636,639.6732,982.4825,638.09 18,524.9514,989.73
Minority Interest3,313.543,884.163,790.864,085.252,851.19 1,921.181,635.08
Long Term Borrowings1,522.611,772.091,436.083,110.301,368.42 48.67115.26
Other Non Current Liabilities1,108.98462.711,341.822,105.512,718.68 2,610.76796.00
Current Liabilities17,339.6219,864.3217,887.0213,143.9616,146.81 5,989.592,841.25
Total Debt*-10,385.279,831.778,496.768,996.11 2,560.86259.71
Total Liabilities64,693.8164,083.8461,095.4555,427.5048,723.19 29,095.1520,377.32
 
AssetsR Cr
Net Block16,381.1318,852.6517,675.1715,872.2512,682.47 6,817.285,647.47
Non Current Investments3,951.813,052.25961.001,116.07598.87 787.561,106.35
Other Non-Current Assets13,291.6810,543.049,505.638,497.886,526.10 2,803.742,120.31
Current Investments3,950.724,090.62230.88713.812,117.43 1,998.461,305.22
Cash and Bank7,275.609,929.3815,140.8413,181.6510,998.04 7,590.154,058.71
Other Current Assets19,842.8717,615.9017,581.9316,045.8415,800.28 9,097.856,139.10
Net Current Assets13,729.5711,771.5815,066.6316,797.3412,768.94 12,696.878,661.78
Miscellaneous Exp. Not Written Off----- 0.110.16
Total Assets64,693.8164,083.8461,095.4555,427.5048,723.19 29,095.1520,377.32
 
Cash FlowR Cr
From Operations-3,907.157,082.216,685.865,615.74 3,959.203,356.58
From Investing Activities--3,370.81-4,221.60-4,371.59-2,865.74 -2,366.76-2,635.05
From Finance Activities--1,539.26-2,285.39-1,888.53-1,186.53 506.57-664.99
Net Inflow/Outflow--1,002.92575.22425.741,563.47 2,099.0156.54
 
Key Ratios
Adjusted EPS (Rs)11.119.0129.0318.8921.92 15.1714.43
Adjusted Book Value (Rs)172.59158.80152.70137.03123.49 89.4472.37
Dividend per Share (Rs)-2.003.501.003.00 1.505.00
Cash Flow per Share (Rs)-16.2829.5227.7827.11 19.1232.41
Debt to Equity0.040.270.270.260.35 0.140.02
Current Ratio1.791.591.842.281.79 3.124.05
ROCE (%)-8.4221.4818.6425.06 25.4631.39
RONW (%)8.017.0522.5119.3224.89 23.1525.53
Operating Margin (%)25.2324.4134.2231.3730.72 46.9646.76
Net Margin (%)10.599.6424.2319.6619.58 23.2729.65
Revenue Growth (%)9.73-15.6311.382.6270.34 42.3140.90
Net Profit Growth (%)21.41-66.3938.533.0741.49 11.6014.21
EPS Growth (%)22.78-68.9653.67-13.8244.50 5.0812.48
Book Value Growth (%)-3.9911.1028.9338.07 23.5822.51
 
Market Cues
Close Price (Rs)392.55495.10688.15820.001,023.90 574.75409.48
High Price (Rs)679.30699.85854.951,200.801,075.00 653.35424.40
Low Price (Rs)344.55432.70571.90704.00570.10 405.00276.50
Market Cap (Rs Cr)94,137.91118,861.32164,999.86197,208.84211,728.42 118,752.2584,748.33
Price / Earnings35.3254.9923.6943.3846.64 37.8028.35
Price / Book Value2.273.124.505.988.28 6.415.65
Dividend Yield (%)0.510.400.510.120.29 0.260.61
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
comments powered by Disqus
Essential checks
Altman Z-Score
4.27
Piotroski F-Score
4
Modified C-Score
3
5-Years Price to Earnings
35.12
5-Years Price to Book
2.26
Earnings Yield
EBIT / Enterprise value
4.85%
PEG
Price / Earnings to growth ratio
-8.42
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R616.90 -3.17%
Biocon R248.30 -3.39%
Cadila Healthcare R245.60 -0.08%
Cipla R555.60 -1.59%
Divi's Laboratories R1,522.30 -1.57%
Dr. Reddy's Lab R2,565.15 -0.89%
Glaxosmithkline Pharma R1,263.05 +0.39%
Lupin R723.20 +0.33%
Piramal Enterprises R2,072.75 -0.21%
Torrent Pharmaceuticals R1,495.65 -2.67%
As on Jun 14, 15:59